Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Enveric Biosciences, Inc.
Report date September 01, 2016 · Filed September 06, 2016
Section 16 reporting ended · disclosed 2016-09-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,276,375 |
Reported balance
After 2016-09-01 transaction · row 1
1 source rowRow 1 · 2016-09-01 · Other · Acquired 299,250 · Balance 6,276,375 F1: Represents shares of Common Stock issued to the Reporting Person in connection with the completion of the Issuer's acquisition of Ameri Consulting Service Private Limited on July 1, 2016, for aggregate consideration consisting of (i) $1.00 and (ii) the consideration furnished by the Issuer to the Reporting Person and Giri Devanur and their affiliates pursuant to that certain Agreement of Merger and Plan of Reorganization, dated as of May 26, 2015, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 26, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock issued to the Reporting Person in connection with the completion of the Issuer's acquisition of Ameri Consulting Service Private Limited on July 1, 2016, for aggregate consideration consisting of (i) $1.00 and (ii) the consideration furnished by the Issuer to the Reporting Person and Giri Devanur and their affiliates pursuant to that certain Agreement of Merger and Plan of Reorganization, dated as of May 26, 2015, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 26, 2015.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2016 Filed Sep 6, 2016 20:30 UTC | Enveric Biosciences, Inc. AMRH · Entity 8193 | OtherCommon Stock | 299,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000921895-16-005632 · form410211002_09062016.xml · nonDerivative · entry 1 Devanur Srinidhi · CIK 0001643489 · Director · Exec. Vice Chairman · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,276,375 F1 · kind: Represents shares of Common Stock issued to the Reporting Person in connection with the completion of the Issuer's acquisition of Ameri Consulting Service Private Limited on July 1, 2016, for aggregate consideration consisting of (i) $1.00 and (ii) the consideration furnished by the Issuer to the Reporting Person and Giri Devanur and their affiliates pursuant to that certain Agreement of Merger and Plan of Reorganization, dated as of May 26, 2015, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 26, 2015. F1 · price: Represents shares of Common Stock issued to the Reporting Person in connection with the completion of the Issuer's acquisition of Ameri Consulting Service Private Limited on July 1, 2016, for aggregate consideration consisting of (i) $1.00 and (ii) the consideration furnished by the Issuer to the Reporting Person and Giri Devanur and their affiliates pursuant to that certain Agreement of Merger and Plan of Reorganization, dated as of May 26, 2015, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 26, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.